Orphan Drugs- development trends and strategies

The development of pharma industries has slowed in recent years because of many reasons such as patent expiries, generic competition, drying pipelines, and increasingly stringent regulatory guidelines. Many blockbuster drugs will lose their exclusivity in next 5 years. Therefore, the current economic situation plus the huge generic competition shifted the focus of pharmaceutical companies from the essential medicines to the new business model — niche busters, also called orphan drugs.

    Related Conference of Orphan Drugs- development trends and strategies

    August 28-29, 2025

    8th Pathology and Infectious Disease Conference

    London, UK
    September 22-23, 2025

    11th International Conference on Infectious and Rare Diseases

    Vancouver, Canada
    December 11-12, 2025

    8th Annual Congress on Bacterial, Viral and Infectious Diseases

    Prague, Czech Republic
    December 15-16, 2025

    7th Global Experts Meeting on Infectious Diseases

    Barcelona, Spain
    December 17-18, 2025

    17th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands

    Orphan Drugs- development trends and strategies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in